No product currently on the market allows women to initiate both HIV prevention and contraception. Renuka and collaborators from the Woodrow lab seek to change this with Empreva, an innovative drug delivery platform that empowers women to take control of their own health.
Q&A with Renuka Ramanathan: BioE Ph.D. student works on Empreva, a prize-winning technology for women’s health
Anti-HIV materials being developed by the Woodrow group could be integrated into a dissolvable, “tampon”-like product that is both easy for women to use and also effective, reports the Huffington Post.
UW Bioengineering Assistant Professor Dr. Kim Woodrow led a Bill and Melinda Gates Foundation youth educational outreach event on July 23, which exposed 6th to 8th graders to a college campus and laboratory and led participants in inquiry-based learning activities about STEM applications for pediatric HIV.
Bioengineers in Dr. Woodrow’s lab have discovered a faster way to deliver a topical drug that can protect women from contracting HIV. The researchers created a fiber material embedded with the drug through a process called electrospinning that quickly dissolves and releases a potent antiretroviral drug, maraviroc, when it comes into contact with moisture.
UW Bioengineering Summer Camp 2014 concludes, teaches high school students about bioengineering, global health
UW Bioengineering Summer Camp 2014 wraps up, teaching 24 high school students about the field of bioengineering and and the field’s solutions for global health problems.
UW Bioengineering Ph.D. student, Cameron Ball, and Assistant Professor Kim Woodrow, demonstrate the potential of a new type of product that may help women protect themselves against sexual HIV transmission. Their research, published online ahead of print in the journal Antimicrobial Agents and Chemotherapy (AAC) of the American Society for Microbiology, shows the ability of water-soluble electrospun fiber material to rapidly release maraviroc, an antiretroviral drug. The researchers suggest that their material offers advantages over other anti-HIV microbicides currently in development.
UW Bioengineering graduate student Anna Blakney receives 2014 GROW with USAID fellowship to study in South Africa. Anna, currently researching in Kim Woodrow’s lab, will spend 6 months at University of Cape Town investigating the timing of the BCG vaccine and HIV acquisition from an immunological perspective.
Hunter Bennett, has been awarded the College of Engineering Dean’s Medal for Academic Excellence for 2014. This honor reflects Hunter’s hard work, leadership, and tremendous contributions to the Department of Bioengineering during his time here. Congratulations, Hunter!
UW Bioengineering assistant professor Dr. Kim Woodrow’s was named on this list, compiled by Newsweek/The Daily Beast to accompany the recent Women in the World Summit. Dr. Woodrow was cited […]